AC
EXAS

Armistice Capital’s Exact Sciences EXAS Stock Holding History

Armistice Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,030,465
Closed -$56.4M – 411
2025
Q3 		$56.4M Buy
1,030,465
+288,509
+39% +$14.4M 0.84% 16
2025
Q2 		$39.4M Sell
741,956
-1,030,413
-58% -$52.3M 0.68% 21
2025
Q1 		$76.7M Buy
1,772,369
+155,369
+10% +$7.87M 1.15% 11
2024
Q4 		$90.9M Buy
+1,617,000
New +$101M 1.24% 9
2024
Q3 		– Sell
-1,400,086
Closed -$59.2M – 283
2024
Q2 		$59.2M Buy
1,400,086
+669,438
+92% +$36.8M 0.74% 17
2024
Q1 		$50.5M Sell
730,648
-41,173
-5% -$2.6M 0.67% 20
2023
Q4 		$57.1M Buy
771,821
+60,301
+8% +$3.95M 0.78% 24
2023
Q3 		$48.5M Buy
711,520
+239,520
+51% +$20.3M 0.74% 25
2023
Q2 		$44.3M Sell
472,000
-884,000
-65% -$69M 0.64% 30
2023
Q1 		$92M Sell
1,356,000
-180,000
-12% -$11.6M 1.32% 12
2022
Q4 		$76M Sell
1,536,000
-24,000
-2% -$981K 1.33% 18
2022
Q3 		$50.7M Buy
+1,560,000
New +$64.3M 0.88% 30
2020
Q4 		– Sell
-40,000
Closed -$4.08M – 114
2020
Q3 		$4.08M Buy
+40,000
New +$3.45M 0.15% 81

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Armistice Capital's EXAS Position: Q4 2025 in Review

Armistice Capital sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 1,030,465 shares — an estimated $56.4M sold.

Armistice Capital first reported a position in EXAS in Q3 2020 and held it in 13 quarters. The position peaked at $92M in Q1 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Armistice Capital reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Armistice Capital sold 1,030,465 Exact Sciences shares in Q4 2025, an estimated $56.4M.
  • Armistice Capital first reported a position in Exact Sciences in Q3 2020 and held it in 13 quarters.
  • Armistice Capital's Exact Sciences position peaked at $92M in Q1 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.